Investigator Profile: Nancy Andreasen, University of Iowa

A sudden interest in medicine after experiencing health complications paved the way for University of Iowa psychiatry Professor and Director of the Iowa Neuroimaging...

Investigator Profile: Nicola Abate, MD

An Endocrinologist with the University of Texas and Bay Area Metabolic Health, he received his medical degree in 1985 from the University of Modena...
Fred Hirsch

Dr. Patrick O’Neil, the Medical University of South Carolina

Dr. O’Neil has been actively involved with the study of semaglutide as a potential treatment for adults with obesity. As a lead investigator, last...

David Hyman, MD, Chief of the Early Drug Dev Services at Memorial Sloan Kettering...

Dr. Hyman was the senior study author of a major trial centering on Larotrectinib (LOXO-101) induced durable responses in patients with TRK fusion-positive solid...

Matthew Smith, MD, PHD, Massachusetts General Hospital Cancer Center

Dr. Smith was lead investigator for a Janssen-sponsored Phase III study which led to the approval of apalutamide (Erleada) for men with prostate cancer...
Female Investigator

Margaret Rosenfeld, MD, MPH, Seattle Children’s Research Institute and Department of Pediatrics, University of...

Dr. Rosenfeld was a lead investigator in the Phase 3 ARRIVAL study, sponsored by Vertex, which found Ivacaftor (KALYDECO®) is generally safe and effective...
Quality Hospital

Aditya H. Gaur, MD, Clinical Director, Department of Infectious Diseases, St. Jude Children’s Research...

Dr. Gaur was lead investigator for a Gilead clinical trial and subsequent drug approval for Biktarvy.® The study evaluated Biktarvy for efficacy and safety...
Investigator Profile

Jonathan Strosberg, MD, Associate Professor, Section Head, Neuroendocrine Tumor Program at Moffitt Cancer Center

Dr. Strosberg was lead investigator for the NETTER-1 trial—sponsored by Novartis’ Advanced Accelerator Applications.  He says “There are very few effective treatment options for...

Investigator Profile: Marie Scully, M.D, Professor of Hematology at University College London Hospitals

Dr. Scully was the lead author of the HERCULES study. The objective of the Phase 3 study pre approval was to evaluate the long...

Ludwig Kappos, University Hospital Basel and Principal Investigator

Professor Kappos was the Principal Investigator for the EXPAND study. The study showed oral siponimod is the first potential therapy to meaningfully delay disability...